
> ONCOLOGY RESEARCH CAPABILITIES
Why RMP for Oncology Studies
Supporting Oncology, Precision Medicine, Radiopharmaceutical, and Biomarker-Driven Clinical Trials Through an Integrated Network of Investigators, Research Sites, and Biospecimen Collection Partners.
As oncology research continues to evolve toward targeted therapies, radiopharmaceuticals, and biomarker-driven treatment approaches, Sponsors require research partners capable of managing increasingly complex protocols.
​
RMP provides access to experienced investigators, integrated clinical sites, biospecimen collection capabilities, and centralized operational oversight designed to support oncology studies from feasibility through closeout.

Oncology Clinical Trial Infrastructure
Hematology-Oncology
Radiation Oncology
Medical Oncology
Precision Medicine Programs
Biomarker-Driven Studies
Radiopharmaceutical Research Readiness

Biospecimen Collection and Laboratory Partnerships
We collaborate with experienced laboratory partners supporting:
-
Blood Collection
-
Tissue Collection
-
PBMC Processing
-
Biomarker Analysis
-
Genomic Testing
-
Sample Processing & Storage
-
Chain of Custody Management
-
Protocol-Specific Laboratory Workflows
Investigator Experience
Oncology Investigators
This model provides access to established patient populations, engaged investigators, and existing clinical infrastructure, creating opportunities for faster recruitment and stronger patient retention.
Therapeutic Experience
Solid Tumors
Hematologic Malignancies
Radiation Oncology
Targeted Therapies
Immuno-Oncology
Precision Medicine
Biomarker Studies
Targeted Therapies
Why Sponsors Choose RMP
Our dedicated research teams work closely with Sponsors and CROs to support:
-
Access to Oncology Patients
-
Integrated Clinical Workflows
-
Biospecimen Collection Support
-
Centralized Quality Oversight
-
Multi-Site Scalability
-
Experienced Investigators



